Raez LE - Search Results

1

Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.

Ruiz R, Hunis B, Raez LE. Ruiz R, et al. Among authors: raez le. Curr Oncol Rep. 2014 Sep;16(9):400. doi: 10.1007/s11912-014-0400-6. Curr Oncol Rep. 2014. PMID: 25030654 Review.

2

New developments in chemotherapy for advanced non-small cell lung cancer.

Raez LE, Lilenbaum R. Raez LE, et al. Curr Opin Oncol. 2006 Mar;18(2):156-61. doi: 10.1097/01.cco.0000208789.37689.6b. Curr Opin Oncol. 2006. PMID: 16462185 Review.

3

Active immunotherapy for non-small-cell lung cancer: moving toward a reality.

Perez CA, Santos ES, Raez LE. Perez CA, et al. Among authors: raez le. Expert Rev Anticancer Ther. 2011 Oct;11(10):1599-605. doi: 10.1586/era.11.155. Expert Rev Anticancer Ther. 2011. PMID: 21999133 Review.

4

Epidermal growth factor vaccine in non-small-cell lung cancer.

Gonzalez Marinello GM, Santos ES, Raez LE. Gonzalez Marinello GM, et al. Among authors: raez le. Expert Rev Anticancer Ther. 2012 Apr;12(4):439-45. doi: 10.1586/era.12.24. Expert Rev Anticancer Ther. 2012. PMID: 22500681 Review.

5

Entinostat (SNDX-275) for the treatment of non-small cell lung cancer.

Ruiz R, Raez LE, Rolfo C. Ruiz R, et al. Among authors: raez le. Expert Opin Investig Drugs. 2015;24(8):1101-9. doi: 10.1517/13543784.2015.1056779. Epub 2015 Jun 22. Expert Opin Investig Drugs. 2015. PMID: 26098363 Review.

6

Entrectinib: a potent new TRK, ROS1, and ALK inhibitor.

Rolfo C, Ruiz R, Giovannetti E, Gil-Bazo I, Russo A, Passiglia F, Giallombardo M, Peeters M, Raez L. Rolfo C, et al. Expert Opin Investig Drugs. 2015;24(11):1493-500. doi: 10.1517/13543784.2015.1096344. Epub 2015 Oct 12. Expert Opin Investig Drugs. 2015. PMID: 26457764 Review.

7

BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?

Caparica R, de Castro G Jr, Gil-Bazo I, Caglevic C, Calogero R, Giallombardo M, Santos ES, Raez LE, Rolfo C. Caparica R, et al. Among authors: raez le. Crit Rev Oncol Hematol. 2016 May;101:32-9. doi: 10.1016/j.critrevonc.2016.02.012. Epub 2016 Feb 27. Crit Rev Oncol Hematol. 2016. PMID: 26960735 Free article. Review.

8

Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?

Pinto JA, Vallejos CS, Raez LE, Mas LA, Ruiz R, Torres-Roman JS, Morante Z, Araujo JM, Gómez HL, Aguilar A, Bretel D, Flores CJ, Rolfo C. Pinto JA, et al. Among authors: raez le. ESMO Open. 2018 Apr 13;3(3):e000344. doi: 10.1136/esmoopen-2018-000344. eCollection 2018. ESMO Open. 2018. PMID: 29682332 Free PMC article.

9

The value of immunotherapy in head and neck cancer.

Manca P, Raez LE, Salzberg M, Sanchez J, Hunis B, Rolfo C. Manca P, et al. Among authors: raez le. Expert Opin Biol Ther. 2019 Jan;19(1):35-43. doi: 10.1080/14712598.2019.1556637. Epub 2018 Dec 20. Expert Opin Biol Ther. 2019. PMID: 30537444 Review.

10

Lung Cancer in the Young.

Galvez-Nino M, Ruiz R, Pinto JA, Roque K, Mantilla R, Raez LE, Mas L. Galvez-Nino M, et al. Among authors: raez le. Lung. 2020 Feb;198(1):195-200. doi: 10.1007/s00408-019-00294-5. Epub 2019 Nov 26. Lung. 2020. PMID: 31773258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page